Gerald L. Hassell - 14 Sep 2022 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anthony Lukaszewski, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Sep 2022
Transactions value $
$7,770
Form type
4
Filing time
16 Sep 2022, 16:25:34
Previous filing
05 Jul 2022
Next filing
03 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $7.77K +117 +0.46% $66.41 25.7K 14 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.